Colossal Biosciences

Ben Lamm

Colossal Spinout Astromech Acquires Sister Company Form Bio for $230M

by | Nov 17, 2026
The all-stock deal brings together two Dallas companies, pairing Astromech’s evolutionary AI models with Form Bio’s tools for designing genetic medicines. Form Bio co-founder Andrew Busey becomes Astromech’s chief AI officer.
MORE►
Galaxy S26 Ultra smartphone
Innovators With DFW Ties Claim 8 Spots on Time’s List of Best Inventions for 2026
by | Oct 20, 2026
Driverless freight, de-extinction science, AI-powered hardware and more land companies with North Texas ties among Time’s 300 picks for the year.
MORE►
Dodo render
Dallas’ Colossal Biosciences Unveils AI Platform to Help Revive the Dodo Bird
by | Oct 14, 2026
The Dallas-based de-extinction company said its GenoMorph platform continues a series of breakthroughs aimed at reviving extinct and endangered species.
MORE►
Ben Lamm

Astromech Raises $20M for Next Phase of Bringing AI to Evolutionary Biology

by | Aug 20, 2026
The Dallas-based Colossal Biosciences spinout, now valued at $3.8 billion, is preparing forecasting pilots in health and biosecurity as it scales the model behind its predictions.
MORE►
Colossal Tasmanian devil facial tumor.
Colossal Foundation Partners with the University of Tasmania to ‘Give Tasmanian Devils a Fighting Chance’
by | Jul 7, 2026
By using a vaccine and gene editing, the partners aim to fight a lethal cancer that has reduced the wild population of Tasmanian devils by 80% since the 1990s.
MORE►
Dallas-Based Colossal and U.S. Fish and Wildlife Service Launch BioVault Initiative for Endangered Species
by | Jun 25, 2026
"By preserving the genetic blueprint of every endangered species in America, we're creating a living archive of Earth's biodiversity—a modern-day Noah's Ark built from DNA and a permanent genetic backup of our nation's most imperiled species," said Colossal Biosciences Co-Founder and CEO Ben Lamm.
MORE►
Colossal Hatches Chicks, Cracks the Egg Problem for Giant Bird De‑Extinction
The Dallas biotech says the shell-less incubation platform could help revive species such as the South Island Giant Moa, whose massive eggs exceed the capacity of any living bird surrogate.
MORE►

Dallas-Based Colossal Gets $60M From U.A.E., Will Build a Modern ‘Noah’s Ark’ in Dubai

by | Feb 3, 2026
"We're losing species at an alarming rate, and the world urgently needs a distributed network of global BioVaults—a true backup plan for life on Earth," said Ben Lamm, Colossal BioSciences' co-founder and CEO.
MORE►
‘There’s So Much Energy in Our Space’: Innovators, Investors Invigorate Sold-Out 2025 Venture Dallas Conference
by | Nov 5, 2025
From North Texas founders including John Carmack and Ben Lamm to investors like John Redgrave of DTX Ventures and Draper’s Andy Tang, the summit's speakers tackled hot topics from humanoid robots and tech transfer to AI, VC trends and Y’all Street. A call was also heard for more risk-taking by DFW’s innovation ecosystem: ‘We’ve got to be bravery hunters.’
MORE►

Colossal Raises Another $120M, Announces Pigeon Cell Breakthrough to Help ‘De‑Extinct’ the Dodo

by | Sep 17, 2025
Dallas-based Colossal Biosciences announced an add-on Series C raise that values it at $10.32 billion. Meanwhile, eggs are being laid in Texas to help advance the "de-extinction" of the famously extinct dodo bird—with a little help from the Nicobar pigeon, the dodo's closest living relative.
MORE►
Dallas-Fort Worth Metro Named ‘AI Star Hub’ in Brookings Report Mapping America’s AI Economy
by | Sep 12, 2025
Dallas-Fort Worth-Arlington joins 30 metro areas driving two-thirds of the country's AI job market.
MORE►
AGI and De-Extinction: John Carmack and Ben Lamm Join Venture Dallas 2025 Lineup
by | Aug 26, 2025
Set for Oct. 30 at the George W. Bush Presidential Center, this year's Venture Dallas conference will assemble more than 500 entrepreneurs, investors, and business leaders for a day of transformative ideas and connections.
MORE►
Colossal Biosciences Names Australian De‑Extinction Scientist as Its Chief Biology Officer
by | Aug 20, 2025
Andrew Pask is known for his expertise in de-extinction science, developmental genetics, and conservation technologies. He leads the Thylacine Integrated Genomic Restoration Research Lab (TIGGR) at the University of Melbourne in Australia.
MORE►